Sunday, April 4, 2021

Cadila seeks nod to repurpose Hepatitis C drug for COVID-19 in India

Cadila seeks nod to repurpose Hepatitis C drug for COVID-19 in India A single dose of the Hepatitis C drug when taken early could help COVID-19 patients recover faster and avoid complications seen in the advanced stages of the disease, Cadila said in a statement to stock exchanges.

from Moneycontrol Business News https://ift.tt/3dy39mn
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

FII exodus deepens in 2026 at Rs 1.75 lakh crore as April outflows swell to Rs 43,967 crore; FOMC next trigger

Foreign institutional investors offloaded Indian equities worth Rs 17,140 crore last week, extending April's outflows to Rs 43,967 crore...